KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Inventory (2016 - 2025)

Cvs Health (CVS) has disclosed Inventory for 17 consecutive years, with $19.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 6.29% year-over-year to $19.2 billion, compared with a TTM value of $19.2 billion through Dec 2025, up 6.29%, and an annual FY2025 reading of $19.2 billion, up 6.29% over the prior year.
  • Inventory was $19.2 billion for Q4 2025 at Cvs Health, up from $19.0 billion in the prior quarter.
  • Across five years, Inventory topped out at $19.2 billion in Q4 2025 and bottomed at $16.1 billion in Q2 2024.
  • Average Inventory over 5 years is $17.8 billion, with a median of $17.7 billion recorded in 2021.
  • The sharpest move saw Inventory dropped 10.5% in 2024, then grew 8.58% in 2025.
  • Year by year, Inventory stood at $17.8 billion in 2021, then rose by 7.49% to $19.1 billion in 2022, then decreased by 5.58% to $18.0 billion in 2023, then rose by 0.45% to $18.1 billion in 2024, then increased by 6.29% to $19.2 billion in 2025.
  • Business Quant data shows Inventory for CVS at $19.2 billion in Q4 2025, $19.0 billion in Q3 2025, and $17.4 billion in Q2 2025.